Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Raggi

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Cells|September 27, 2024
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma CellsGiorgia Ciufolini, Serena Zampieri, Simona Cesaroni, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2022
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediatorsMirella Pastore, Alessandra Caligiuri, Chiara Raggi, et al.
Gastroenterology|March 26, 2013
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell typesÁgnes Holczbauer, Valentina M Factor, Jesper B Andersen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaSilvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Oncogenesis|October 24, 2019
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsGiovanni Di Maira, Alessandra Gentilini, Mirella Pastore, et al.
Oncotarget|June 25, 2019
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinomaTeresa Pollicino, Cristina Musolino, Carlo Saitta, et al.
Hepatology (Baltimore, Md.)|May 28, 2011
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathwaysJens U Marquardt, Chiara Raggi, Jesper B Andersen, et al.
Molecular Cancer Therapeutics|February 22, 2023
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in CholangiocarcinomaGiulia Anichini, Chiara Raggi, Mirella Pastore, et al.
International Journal of Molecular Sciences|September 27, 2025
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic CholangiocarcinomaErwin Gäbele, Isabella Gigante, Mirella Pastore, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cells|September 27, 2024
3D Modeling: Insights into the Metabolic Reprogramming of Cholangiocarcinoma CellsGiorgia Ciufolini, Serena Zampieri, Simona Cesaroni, et al.
JHEP Reports : Innovation in Hepatology|March 7, 2022
Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediatorsMirella Pastore, Alessandra Caligiuri, Chiara Raggi, et al.
Gastroenterology|March 26, 2013
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell typesÁgnes Holczbauer, Valentina M Factor, Jesper B Andersen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2019
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinomaSilvestre Vicent, Ruby Lieshout, Anna Saborowski, et al.
Oncogenesis|October 24, 2019
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsGiovanni Di Maira, Alessandra Gentilini, Mirella Pastore, et al.
Oncotarget|June 25, 2019
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinomaTeresa Pollicino, Cristina Musolino, Carlo Saitta, et al.
Hepatology (Baltimore, Md.)|May 28, 2011
Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathwaysJens U Marquardt, Chiara Raggi, Jesper B Andersen, et al.
Molecular Cancer Therapeutics|February 22, 2023
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in CholangiocarcinomaGiulia Anichini, Chiara Raggi, Mirella Pastore, et al.
International Journal of Molecular Sciences|September 27, 2025
The DNA Minor Groove Binders Trabectedin and Lurbinectedin Are Potent Antitumor Agents in Human Intrahepatic CholangiocarcinomaErwin Gäbele, Isabella Gigante, Mirella Pastore, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
Pageof 6